OBJECTIVES: Smoking is an important risk factor leading to many diseases, which brings substantial healthcare costs as well as indirect costs due to decreased productivity. This article aims to quantify the social costs of smoking in the Czech Republic in 2019. METHODS: The prevalence-based, cost-of-illness approach is used, which assesses the costs as the sum of direct (healthcare) costs and indirect costs (productivity losses due to mortality and morbidity). The costs of healthcare utilization and pharmacotherapy in direct costs, and the costs of absenteeism, presenteeism, and premature mortality in indirect costs, are included. RESULTS: Total costs of smoking in the Czech Republic in 2019 are estimated as 2110.6 million EUR (0.94% of GDP). Direct costs amounted to 537.0 million EUR (2.9% of health expenditures in 2019) and indirect costs were 1573.6 million EUR, mainly driven by the costs of premature mortality (1062.5 million EUR). CONCLUSIONS: Despite the declining trend in the prevalence of smoking in the Czech Republic, the associated costs are considerable. Investments into strategies to reduce smoking continue to be needed.

Faculty of Social Sciences Institute of Economic Studies Charles University Opletalova 26 110 00 Prague Czech Republic

Zobrazit více v PubMed

Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, Abbafati C, Abera SF, Abraham B, Abyu GY, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: A systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906. 10.1016/S0140-6736(17)30819-X. PubMed PMC

WHO. Tobacco. https://www.who.int/news-room/fact-sheets/detail/tobacco, Jul 2023a. Accessed 17 Jan 2024.

OECD. Non-medical determinants of health. https://www.oecd-ilibrary.org/content/data/data-00546-en, 2016. Accessed 17 Jan 2024.

The Tobacco Atlas. Product sales: cigarette consumption. https://tobaccoatlas.org/downloads/?_categories=product-sales, 2019. Accessed 17 Jan 2024.

IHIS. Vybrané výsledky ze šetření EHIS v roce 2019. Tabulka 4: Kuřáci tabákových výrobků a konzumace alkoholu podle pohlaví a věkových skupin v roce 2019 (selected results from EHIS 2019. Table 4: Tobacco smokers and alcohol consumption stratified by gender and age groups in 2019)). https://www.czso.cz/csu/czso/vybrane-vysledky-ze-setreni-ehis-v-roce-2019, 2020. Accessed 23 Oct 2023.

National Institute of Public Health, Csemy L, Dvorakova Z, Fialova A, Kodl M, Maly M, Skyvova M. National research of tobacco and alcohol usage in the Czech Republic, 2022. https://mzd.gov.cz/wp-content/uploads/2023/05/NAUTA_2022.pdf, (2023). Accessed 05 Jul 2024.

Makate M, Whetton S, Tait RJ, Dey T, Scollo M, Banks E, Norman R, Pidd K, Roche AM, Allsop S. Tobacco cost of illness studies: a systematic review. Nicotine Tob Res. 2020;22(4):458–65. 10.1093/ntr/ntz038. PubMed

Cher BP, Chen C, Yoong J. Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore. BMJ Open. 2017;7(4): e014377. 10.1136/bmjopen-2016-014377. PubMed PMC

Koronaiou K, Delipalla S. The economic cost of tobacco smoking and secondhand smoke in Greece: musculoskeletal disorders the leading contributor to smoking-related morbidity. Tobacco Prevent Cessat. 2019. 10.18332/tpc/113091. PubMed PMC

Goodchild M, Nargis N, d’Espaignet ET. Global economic cost of smoking-attributable diseases. Tob Control. 2018;27(1):58–64. 10.1136/tobaccocontrol-2016-053305. PubMed PMC

Jarvis A, Vincze MP, Falconer B, Garde A, Frederic G, Daynard R. A study on liability and the health costs of smoking. London, United Kingdom: GHK, 2012. 10.18332/tpc/113091. Accessed 11 Nov 2023.

Lasocka J, Jakubczyk M, Siekmeier R. Costs of smoking-attributable productivity losses in Poland. In: Respiratory regulation-clinical advances, 2013; pp. 179–187. Springer. 10.1007/978-94-007-4546-9_23. PubMed

Shrestha SS, Ghimire R, Wang X, Trivers KF, Homa DM, Armour BS. Cost of cigarette smoking-attributable productivity losses, US, 2018. Am J Prev Med. 2022;63(4):478–85. 10.1016/j.amepre.2022.04.032. PubMed PMC

Whetton S, Allsop S, Tait R, Scollo M, Banks E, Chapman J, Dey T, Halim S, Makate M, McEntee A, Muhktar A, Norman R, Pidd K, Roche A. Identifying the social costs of tobacco use to Australia in 2015/16. National Drug Research Institute, 05 2019.

US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.

Hans K, Joshua K, Jacqueline K. Variation across Canada in the economic burden attributable to excess weight, tobacco smoking and physical inactivity. Can J Public Health. 2015;106:e171–7. 10.17269/cjph.106.4994. PubMed PMC

Lievens D, Laenen FV, Verhaeghe N, Putman K, Pauwels L, Hardyns W, Annemans L. Economic consequences of legal and illegal drugs: the case of social costs in Belgium. Int J Drug Policy. 2017;44:50–7. 10.1016/j.drugpo.2017.03.005. PubMed

Sung H-Y, Chang L-C, Wen Y-W, Tsai Y-W. The costs of smoking and secondhand smoke exposure in Taiwan: a prevalence-based annual cost approach. BMJ Open. 2014;4(7): e005199. 10.1136/bmjopen-2014-005199. PubMed PMC

Collins D, Lapsley HM. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. 01 2008. 10.1037/e674312010-001.

3rd Bunn WB, Stave GM, Downs KE, Alvir JMJ, Dirani R. Effect of smoking status on productivity loss. J Occup Environ Med. 2006. 10.1097/01.jom.0000243406.08419.74. PubMed

Burton WN, Chen C-Y, Conti DJ, Schultz AB, Pransky G, Edington DW. The association of health risks with on-the-job productivity. J Occup Environ Med. 2005. 10.1097/01.jom.0000169088.03301.e4. PubMed

Berman M, Crane R, Seiber E, Munur M. Estimating the cost of a smoking employee. Tob Control. 2014;23(5):428–33. 10.1136/tobaccocontrol-2012-050888. PubMed

Medibank. Sick at work. The cost of presenteeism to your business and the economy. https://www.medibank.com.au/content/dam/client/documents/pdfs/sick_at_work.pdf, 2011. Accessed 01 Nov 2023.

Bolin K, Borgman B, Gip C, Wilson K. Current and future avoidable cost of smoking-estimates for Sweden 2007. Health Policy. 2011;103(1):83–91. 10.1016/j.healthpol.2011.08.011. PubMed

Inc. Arthur D. Little International. Public finance balance of smoking in the Czech Republic. Report to Philip Morris CR a.s. http://www.tobacco.org/Documents/001128pmlittleczech.html, 2000. Accessed 11 Nov 2023.

Ross H. Critique of the Philip Morris study of the cost of smoking in the Czech Republic. Nicotine Tobacco Res. 2004;6(1):181–9. 10.1080/14622200310001657000. PubMed

Sovinová H, Csémy L, Procházka B, Kottnauerová S, et al. Smoking attributable hospital treatment, treatment costs and smoking attributable mortality in the Czech Republic in 2002. Cent Eur J Public Health. 2007;15(2):79–83. 10.21101/cejph.a3417. PubMed

Kolichová Š. Kouření v těhotenství. https://theses.cz/id/ckskqk/, 2011. Accessed 10 Nov 2023.

Anh PTH, Ross H, Anh NQ, Linh BN, Minh NT, et al. Direct and indirect costs of smoking in Vietnam. Tob Control. 2016;25(1):96–100. 10.1136/tobaccocontrol-2014-051821. PubMed PMC

Boachie MK, Rossouw L, Ross H. The economic cost of smoking in South Africa, 2016. Nicotine Tob Res. 2021;23(2):286–93. 10.1093/ntr/ntaa162. PubMed PMC

IHIS. National registry of reimbursed health services, 2019a. Data obtained upon author’s request.

GHIF. Yearbook of ghif in 2019, source tables. https://www.vzp.cz/o-nas/dokumenty/rocenky, 2019. Accessed 30 Oct 2023.

IHIS. Information system incapacity for work, 2019b. Data obtained upon author’s request.

IHIS. Information system deaths, 2019c. Data obtained upon author’s request.

CSO. Structure of earnings survey - 2019: A3 percentage of employees, time paid and gross monthly earnings by age and by sex. https://www.czso.cz/csu/czso/structure-of-earnings-survey-2019, 2023. Accessed 27 Oct 2023.

CAS. Jak Češi tráví čas? Výsledky 1. ročníku výzkumu proměny české společnosti 2015 (how do czechs spend their free time? results of the first survey of change in czech society 2015. https://www.promenyceskespolecnosti.cz/aktuality/aktualita22/Jak_Cesi_travi_cas_TK_20-06-2016.pdf, 2016. Accessed 30 Oct 2023.

AEIS. Informační systém o průměrném výdělku - Mzdová sféra ČR 2019 (Average Earnings Information System - Wages in CR in 2019. https://www.ispv.cz/cz/Vysledky-setreni/Archiv/2019.aspx, 2019. Accessed 30 Oct 2023.

CSO. Life Tables for the Czech Republic, Cohesion Regions, and Regions—2018–2019: Complete life tables for the Czech Republic for 2019 (Males and Females). https://www.czso.cz/csu/czso/life-tables-for-the-czech-republic-cohesion-regions-and-regions-2018-2019, 2019. Accessed 01 Nov 2023.

WHO. Life tables by country (GHE: Life tables). https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-ghe-life-tables-by-country, 2023b. Accessed 10 Nov 2023.

Tereza H. Ekonomické dopady rostoucí incidence obezity na zdravotnictví v ČR (Diplomová práce)/Economic consequences of growing incidence of obesity on healthcare in the Czech Republic. Master’s thesis, Vysoká škola ekonomická, Institut managementu zdravotnických služeb, 2009.

Dee A, Callinan A, Doherty E, O’Neill C, McVeigh T, Sweeney MR, Staines A, Kearns K, Fitzgerald S, Sharp L, et al. Correction. Overweight and obesity on the island of Ireland: an estimation of costs. BMJ Open. 2015. 10.1136/bmjopen-2014-006189corr1. PubMed PMC

Stefler D, Murphy M, Irdam D, Horvat P, Jarvis M, King L, McKee M, Bobak M. Smoking and mortality in eastern europe: Results from the privmort retrospective cohort study of 177 376 individuals. Nicotine Tobacco Res. 2018;20(6):749–754. https://www.jstor.org/stable/26771736. PubMed

Pike J, Grosse SD. Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review. Appl Health Econ Health Policy. 2018;16(6):765–78. 10.1007/s40258-018-0416-4. PubMed PMC

Koopmanschap MA, Rutten FFH, Martin Van Ineveld B, Van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171–89. 10.1016/0167-6296(94)00044-5. PubMed

Kigozi J, Jowett S, Lewis M, Barton P, Coast J. The estimation and inclusion of presenteeism costs in applied economic evaluation: a systematic review. Value Health. 2017;20(3):496–506. 10.1016/j.jval.2016.12.006. PubMed

Hanly P, Ortega MO, Pearce A, Soerjomataram I, Sharp L. Advances in the methodological approach to friction period estimation: a European perspective. Soc Sci Med. 2020;264: 113289. 10.1016/j.socscimed.2020.113289. PubMed

Chadimova K, Mlcoch T, Dolejsi D, Hajickova B, Mazalova M, Lamblova K, Dolezal T. The economic burden of alcohol consumption in the Czech Republic. Value Health. 2019;22:S686. 10.1016/j.jval.2019.09.1506.

Landovská P, Karbanová M. Social costs of obesity in the Czech Republic. Eur J Health Econ. 2023;24(8):1321–41. 10.1007/s10198-022-01545-8. PubMed PMC

Brouwer WBF, Koopmanschap MA. The friction-cost method: replacement for nothing and leisure for free? Pharmacoeconomics. 2005;23:105–11. 10.2165/00019053-200523020-00002. PubMed

Neubauer S, Welte R, Beiche A, Koenig H-H, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control. 2006;15(6):464–71. 10.1136/tc.2006.016030. PubMed PMC